Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis

Clinical trial NCT05488327 · UNKNOWN

Trial details

NCT number: NCT05488327
Sponsor: Jiangxi Provincial People's Hopital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Dermatomyositis

Start date: 2022-08-01
Primary completion: 2023-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.